The Etiology of New-onset Status Epilepticus

Completed

• Conditions: Status Epilepticus
• Interventions: Diagnostic Test: Perform autoimmune encephalitis titer tests

• Registration Number: NCT05647525
• Lead Sponsor: Jie Liu

Brief Summary

This study will help to identify the causes of new epilepsy and provide a basis for the development of a rational and standardized diagnosis and treatment plan to reduce the rate of disability and death.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-01
• Primary Completion: 2022-08-30
• Study Completion: 2022-09-30
• Status Verified: 2022-12
• Study First Submitted: 2022-12-04
• Study First Submitted QC: 2022-12-04
• Study First Posted: 2022-12-12
• Last Update Submitted: 2022-12-13
• Last Update Posted: 2022-12-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Clinical diagnosis of Status Epilepticus
• Sign the informed consent form

Exclusion Criteria

• Patients with previous epilepsy
• Missing information such as basic information and treatment history
• Long-term smoking, alcohol and drug abuse
• Pregnant and breastfeeding women

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
status epilepticus with autoimmune encephalitis; status epilepticus without autoimmune encephalitis	Perform autoimmune encephalitis titer tests	To study the relationship between autoimmune-related antibody titres and prognosis during the six-month follow-up

Primary Outcome Measures

Name	Time	Method
Death	2021-12--2022-12

Trial Locations

Locations (1)

Jie Liu; 🇨🇳 Chengdu, Sichuan, China